AstraZeneca's 7% Stock Surge and $1.5B AI Bet Signal Pharma's Next Frontier
AstraZeneca shares jumped 7% after Q3 earnings beat forecasts, with the drugmaker unveiling a $1.5 billion savings plan to bankroll its artificial intelligence drug pipeline.…